Nuveen Asset Management, LLC Ani Pharmaceuticals Inc Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 182,028 shares of ANIP stock, worth $10.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

182,028

Previous 319,142 42.96%

Holding current value

$10.3 Million

Previous $20.3 Million 46.57%

% of portfolio

0.0%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$54.33 - $65.72 $7.45 Million - $9.01 Million	-137,114 Reduced 42.96%	182,028 $10.9 Million
Q2 2024 Aug 09, 2024	BUY	$58.53 - $68.82 $4.27 Million - $5.02 Million	72,986 Added 29.65%	319,142 $20.3 Million
Q1 2024 May 13, 2024	BUY	$54.2 - $69.69 $4.71 Million - $6.05 Million	86,862 Added 54.53%	246,156 $17 Million
Q4 2023 Feb 14, 2024	SELL	$48.72 - $65.43 $3.03 Million - $4.07 Million	-62,137 Reduced 28.06%	159,294 $8.78 Million
Q3 2023 Nov 14, 2023	BUY	$50.28 - $64.61 $9.08 Million - $11.7 Million	180,491 Added 440.87%	221,431 $12.9 Million
Q1 2023 May 15, 2023	SELL	$37.61 - $45.72 $149,574 - $181,828	-3,977 Reduced 8.85%	40,940 $1.63 Million
Q4 2022 Feb 14, 2023	SELL	$31.9 - $41.95 $195,068 - $256,524	-6,115 Reduced 11.98%	44,917 $1.81 Million
Q3 2022 Nov 14, 2022	SELL	$29.83 - $38.01 $17,957 - $22,882	-602 Reduced 1.17%	51,032 $1.64 Million
Q2 2022 Aug 15, 2022	BUY	$23.09 - $33.46 $290,010 - $420,257	12,560 Added 32.14%	51,634 $1.53 Million
Q1 2022 May 16, 2022	BUY	$26.91 - $47.15 $92,220 - $161,583	3,427 Added 9.61%	39,074 $1.05 Million
Q4 2021 Feb 14, 2022	SELL	$32.97 - $56.85 $104,415 - $180,043	-3,167 Reduced 8.16%	35,647 $1.6 Million
Q3 2021 Nov 12, 2021	SELL	$26.48 - $35.99 $58,256 - $79,178	-2,200 Reduced 5.36%	38,814 $1.12 Million
Q2 2021 Aug 16, 2021	SELL	$31.86 - $38.6 $164,907 - $199,793	-5,176 Reduced 11.21%	41,014 $1.44 Million
Q1 2021 May 17, 2021	BUY	$28.4 - $36.14 $111,384 - $141,741	3,922 Added 9.28%	46,190 $1.67 Million
Q4 2020 Feb 16, 2021	BUY	$23.69 - $31.47 $90,993 - $120,876	3,841 Added 10.0%	42,268 $1.23 Million
Q3 2020 Nov 16, 2020	BUY	$26.38 - $33.1 $3,614 - $4,534	137 Added 0.36%	38,427 $1.08 Million
Q2 2020 Aug 14, 2020	SELL	$29.93 - $50.1 $615,241 - $1.03 Million	-20,556 Reduced 34.93%	38,290 $1.24 Million
Q1 2020 May 14, 2020	SELL	$30.35 - $67.14 $91,565 - $202,561	-3,017 Reduced 4.88%	58,846 $2.4 Million
Q4 2019 Feb 14, 2020	SELL	$55.65 - $79.83 $281,366 - $403,620	-5,056 Reduced 7.56%	61,863 $3.82 Million
Q3 2019 Nov 14, 2019	SELL	$64.7 - $85.39 $1.24 Million - $1.63 Million	-19,100 Reduced 22.2%	66,919 $4.88 Million
Q2 2019 Aug 15, 2019	BUY	$67.77 - $82.2 $5.83 Million - $7.07 Million	86,019 New	86,019 $7.07 Million

Others Institutions Holding ANIP

# of Institutions

211

Shares Held

18.8M

Call Options Held

11.7K

Put Options Held

10.5K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $986M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Ani Pharmaceuticals Inc Transaction History